Real-time enrollment status for this immunoglobulin a nephropathy (igan) clinical trial
Current Status
Recruiting
Checked: October 27, 2026 at 5:34 PM UTC
| NCT Number | NCT07773727 |
| Recruiting Status | Recruiting |
| Condition | Immunoglobulin A Nephropathy (IgAN) |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 9 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | October 27, 2026 (17 hours ago) |
As of October 27, 2026: Clinical trial NCT07773727 is currently recruiting participants. This phase2 study for immunoglobulin a nephropathy (igan) is actively seeking new participants at 9 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07773727 is actively recruiting participants as of October 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07773727 was last updated 17 hours ago (October 27, 2026). HelloStudys verifies this status automatically.